Yoshihiro Arai
Vorstandsvorsitzender bei SOLASIA PHARMA K.K.
Vermögen: 190 754 $ am 30.04.2024
Aktive Positionen von Yoshihiro Arai
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SOLASIA PHARMA K.K. | Direktor/Vorstandsmitglied | 01.02.2013 | - |
Vorstandsvorsitzender | 01.02.2013 | - | |
Präsident | 01.02.2013 | - | |
Corporate Officer/Principal | 01.09.2007 | 01.02.2013 |
Karriereverlauf von Yoshihiro Arai
Ehemalige bekannte Positionen von Yoshihiro Arai
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Searle Yakuhin KK | Corporate Officer/Principal | - | - |
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Corporate Officer/Principal | - | - |
Ausbildung von Yoshihiro Arai
University of Wales (Bangor) | Masters Business Admin |
Tokyo University of Pharmacy & Life Science | Graduate Degree |
Statistik
International
Japan | 4 |
Vereinigtes Königreich | 2 |
2 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Health Technology |
Solasia Pharma KK | |
Searle Yakuhin KK |
- Börse
- Insiders
- Yoshihiro Arai
- Erfahrung